Human Mesenchymal Stem Cell-Treated Regulatory CD23(+)CD43(+) B Cells Alleviate Intestinal Inflammation

Rationale: Mesenchymal stem cells (MSCs) have been demonstrated to ameliorate inflammatory bowel disease by their actions on multiple immune cells, especially on regulatory B cells (Breg cells). However, the phenotypes and functions of human MSCs (hMSCs)-treated Breg cell subsets are not yet clear....

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaoyong, Cai, Chuang, Xu, Dijing, Liu, Qiuli, Zheng, Shuwei, Liu, Longshan, Li, Gang, Zhang, Xiaoran, Li, Xiaoping, Ma, Yuanchen, Huang, Li, Chen, Jieying, Shi, Jiahao, Du, Xin, Xia, Wenjie, Xiang, Andy Peng, Peng, Yanwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643430/
https://www.ncbi.nlm.nih.gov/pubmed/31367246
http://dx.doi.org/10.7150/thno.32260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643430/
https://www.ncbi.nlm.nih.gov/pubmed/31367246
http://dx.doi.org/10.7150/thno.32260

Ejemplares similares